Search results
Aditya Birla Sun Life AMC Ltd Stock Price: Aditya AMC Share Price Today | India Infoline
India Infoline· 4 hours agoAditya AMC Share Price: Get the live NSE/BSE stock price of Aditya Birla Sun ...
Akiko Global Services Ltd Share Price Today, AKIKO Share Price NSE, BSE
Business Today· 2 days agoAkiko Global Services Ltd Share price NSE, BSE today: check share/stock price of AKIKO, get live...
LIC raises stake in IDFC First Bank to 2.68% at ₹80.63/share via private placement offer | Mint
Livemint· 7 hours agoLIC raised its stake in IDFC First Bank to 2.68% at ₹80.63 per share via a private placement offer...
Birla’s UltraTech buys 23% in India Cements in mkt share race with Adani cos - Times of India
The Times of India· 7 days agoMUMBAI/CHENNAI: UltraTech Cement, controlled by Kumar Mangalam Birla, has acquired a 23% stake in...
UltraTech Cement, part of Aditya Birla Group, buys 23% of Chennai's India Cements for Rs 1,885 crore
SiliconIndia· 6 days agoRenowned cement producing brand Ultratech cement led by Kumar Mangalam Birla is all set to acquire...
Hindalco Inds. Summary: Latest Updates and Details | India Infoline
India Infoline· 1 day agoHindalco Industries Ltd Summary: Check out the latest management information and corporate updates of Hindalco Inds. at India Infoline
Dhyaani Tradeventures Competitors List - Compare Dhyaani Tradeventures Quotes - The Economic Times
The Economic Times· 1 day agoDhyaani Tradeventures Competitors List - Compare Dhyaani Tradeventures with its Competitors in terms of Share Price, Stock price forecast, trends, charts and more on The Economic Times
Stock Radar: HDFC Bank, Yes Bank, D-Mart, IEX, Zomato, KEC in focus on Wednesday
CNBC Awaaz· 2 days agoOriental Carbon and Chemicals, Orient Cement, Pearl Global Industries, Allcargo Gati, Piramal...
Telecom competition takes a breather, may recharge Vodafone Idea - ET Telecom
The Economic Times· 2 days agoBrokerage Citi Research projected rising revenues, operating income, capex, and narrowing losses for...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 12 hours agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...